Cancer Family
Nervous System Neoplasm
CI-CAN-00000038Explore in graph →
Non-malignant1,525 active trials9 approved drugs210 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000038Explore in graph →
Clinical trials
5,876 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01238237 | Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA | completed | Phase 1 | 15 | Northwell HealthOTHER | 1 | Feb 1, 2017 | clinicaltrials |
| NCT00813943 | Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status(CORE) | completed | Phase 2 | 265 | EMD SeronoINDUSTRY | 2 | Jan 30, 2017 |
| clinicaltrials |
| NCT01903967 | Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)(PITUIGENE) | completed | — | 213 | Hospices Civils de LyonOTHER | 1 | Jan 23, 2017 | clinicaltrials |
| NCT02315989 | Early-Phase Safety of Proton Therapy Equipment | completed | N/A | 6 | Chang Gung Memorial HospitalOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT00085540 | FR901228 in Treating Patients With Recurrent High-Grade Gliomas | completed | Phase 1 / Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 2, 2017 | clinicaltrials |
| NCT00777153 | Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma(REGAL) | completed | Phase 3 | 423 | AstraZenecaINDUSTRY | 10 | Dec 28, 2016 | clinicaltrials |
| NCT01269918 | A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain(RemivsDex) | completed | N/A | 142 | The Cleveland ClinicOTHER | 1 | Dec 20, 2016 | clinicaltrials |
| NCT00718783 | Molecular Analysis of Retinoblastoma | completed | — | 41 | St. Jude Children's Research HospitalOTHER | 2 | Dec 14, 2016 | clinicaltrials |
| NCT00857519 | A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma(IAC-RB) | completed | N/A | 10 | Wills EyeOTHER | 1 | Dec 12, 2016 | clinicaltrials |
| NCT01577966 | Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma | completed | N/A | 9 | University of Alabama at BirminghamOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT00532948 | A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas | completed | Phase 1 | 24 | Hoffmann-La RocheINDUSTRY | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00165542 | A-protein Levels in Adult and Pediatric Brain Tumor Patients | completed | — | 54 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT00705198 | Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062) | completed | — | 1,804 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 15, 2016 | clinicaltrials |
| NCT02450019 | Protective Ventilation in Neurosurgery, a Pilot Study(NeuroVentOR) | completed | N/A | 40 | IRCCS San RaffaeleOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02963896 | Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma(ITG) | completed | N/A | 20 | University Hospital, MotolOTHER | 0 | Nov 15, 2016 | clinicaltrials |
| NCT00723463 | Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue | completed | Early Phase 1 | 200 | University of MichiganOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01308684 | A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma | completed | Phase 1 | 22 | Hoffmann-La RocheINDUSTRY | 4 | Nov 2, 2016 | clinicaltrials |
| NCT01547546 | A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma | completed | Phase 1 | 29 | Genentech, Inc.INDUSTRY | 2 | Nov 2, 2016 | clinicaltrials |
| NCT01443676 | Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma(ARTE) | completed | Phase 2 | 75 | University of ZurichOTHER | 1 | Nov 1, 2016 | clinicaltrials |
| NCT00328575 | Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases | completed | Phase 1 | 10 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Oct 21, 2016 | clinicaltrials |
| NCT01999270 | Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors | completed | Phase 1 | 6 | Washington University School of MedicineOTHER | 1 | Oct 21, 2016 | clinicaltrials |
| NCT00793351 | Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation | completed | Phase 2 | 25 | Samsung Medical CenterOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00890032 | Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme | completed | Phase 1 | 50 | John SampsonOTHER | 1 | Oct 17, 2016 | clinicaltrials |
| NCT02104882 | INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study | completed | Phase 1 / Phase 2 | 12 | Universitätsmedizin MannheimOTHER | 1 | Oct 17, 2016 | clinicaltrials |
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT01538095 | Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 2 | Oct 3, 2016 | clinicaltrials |
| NCT02810899 | Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy | completed | Phase 4 | 60 | Peking University First HospitalOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT02913534 | Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy | completed | — | 100 | Institut de Cancérologie de LorraineOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT00088400 | Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors | completed | Phase 3 | 30 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00280475 | A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis | completed | Phase 3 | 270 | Haruhiko FukudaOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT02558569 | The Use of Fentanyl in General Anesthesia for Craniotomy With or Without 0.5% Levobupivacaine Scalp Block | completed | Phase 4 | 128 | Mahidol UniversityOTHER | 1 | Sep 14, 2016 | clinicaltrials |
| NCT02899663 | MRI Detection of Microbleeds in Glioma Patients(SWIGLI) | completed | — | 58 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 0 | Sep 14, 2016 | clinicaltrials |
| NCT02898012 | Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status(ATAG) | completed | Phase 2 | 70 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT00544817 | Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme | completed | Phase 2 | 47 | SCRI Development Innovations, LLCOTHER | 1 | Sep 1, 2016 | clinicaltrials |
| NCT01371643 | Surgical Debulking of Pituitary Adenomas | completed | Phase 4 | 41 | NYU Langone HealthOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01620138 | Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas | completed | Phase 2 / Phase 3 | 21 | Universidade Federal do Rio de JaneiroOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT00302159 | Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Aug 18, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02861222 | Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma(MYOCET) | completed | Phase 1 | 13 | Central Hospital, Nancy, FranceOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT00960739 | Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma(MIITOP) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT02267928 | Information Presentation Formats | completed | N/A | 305 | Carnegie Mellon UniversityOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT00766467 | A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas | completed | Phase 2 | 81 | Eudocia Quant Lee, MDOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT02057367 | Scalp Nerve Block and Opioid Consumption in Brain Surgery | completed | Phase 4 | 100 | Chiang Mai UniversityOTHER | 1 | Jul 27, 2016 | clinicaltrials |
| NCT00899834 | DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma | completed | — | 81 | St. Jude Children's Research HospitalOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT01331291 | Bosutinib in Adult Patients With Recurrent Glioblastoma | completed | Phase 2 | 36 | Massachusetts General HospitalOTHER | 1 | Jul 25, 2016 | clinicaltrials |
| NCT02291822 | Retrospective Study of MRI in Pediatric Patients | completed | — | 90 | Bracco Diagnostics, IncINDUSTRY | 0 | Jul 19, 2016 | clinicaltrials |
| NCT00125697 | Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy | completed | — | 49 | AHS Cancer Control AlbertaOTHER | 1 | Jul 18, 2016 | clinicaltrials |
| NCT00125710 | Comparative 2-D Tumor Analysis in Familial Gliomas | completed | — | 5 | AHS Cancer Control AlbertaOTHER | 1 | Jul 18, 2016 | clinicaltrials |
| NCT02063295 | An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury | completed | Phase 2 | 14 | Zafgen, Inc.INDUSTRY | 2 | Jul 18, 2016 | clinicaltrials |
| NCT01204476 | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 15, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Feb 1, 2017source: clinicaltrials